NEW YORK – PixCell Medical is laying the groundwork for a full commercial launch of its point-of-care HemoScreen platform in the US while carrying out development of a new test panel for sepsis.
NEW YORK – PixCell Medical is laying the groundwork for a full commercial launch of its point-of-care HemoScreen platform in the US while carrying out development of a new test panel for sepsis.
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.